The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Drug makers expedite production for front-line use
The top drug regulator in North China's Hebei province has started an express approval channel for local drug makers manufacturing medical products that can be used in the fight against the novel coronavirus.
February07,2020
Chinese drugmakers' earnings weaken on pricing pressure: Fitch
Chinese drug manufacturers' earnings are likely to remain under pressure due to price curbing measures, with increasing divergence in performance between common generic and innovative drugmakers, according to the latest Fitch Ratings report provided to Xinhua.
September23,2019
China-funded drug rehab center unveiled in S. Philippines
A Chinese government-financed drug treatment and rehabilitation center in southern Philippines' Agusan del Sur province was turned over to the local government on Monday.
April09,2019
China unveils pilot "group-buying" plan to cut drug prices
China has unveiled a pilot medicine procurement program to be tried in 11 major cities to lower drug prices and reduce the burden on patients.
January18,2019
CAS unveils drug discovery and dev. center in Uzbekistan to promote S&T cooperation
The Chinese Academy of Sciences (CAS) inaugurated the Central Asian Center of Drug Discovery and Development in Uzbekistan's capital Tashkent on November 23, in a bid to foster science and technology cooperation between China and Central Asia.
November27,2018
China removes import tariffs on all cancer drugs
China on Tuesday has exempted import tariffs on all common drugs including cancer drugs, cancer alkaloid-based drugs, and imported traditional Chinese medicine.
May03,2018
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.